Antibodies against tyrosinase-related protein-2, a protein highly expressed in cutaneous melanoma [76], were detected in a larger proportion of patients with vitiligo than in those without, suggesting increased autoimmunity against melanoma cells in those who developed vitiligo [56]. Here, DCT is linked to vitiligo.